Showing results (61-70 of 103) with videos related to
Sort By:
Pageof 11
Biochemical Pharmacology|March 27, 1998
Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissuesM T Kuo, J Bao, M Furuichi, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)K Lu, N Savaraj, J Kavanagh, et al.Journal of Neuro-Oncology|January 1, 1985
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignanciesE A Obbens, L G Feun, M E Leavens, et al.Journal of Neuro-Oncology|January 1, 1987
Central nervous system (CNS) penetration of homoharringtonine (HHT)N Savaraj, L G Feun, K Lu, et al.Cancer Drug Delivery|January 1, 1986
Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumorsL G Feun, Y Y Lee, W K Yung, et al.American Journal of Clinical Oncology|August 1, 1997
Multidrug-resistant gene expression in small-cell lung cancerN Savaraj, C J Wu, R Xu, et al.Oncology Reports|May 19, 2011
Comparison of topoisomerase I and II expression in primary brain tumor and lung cancerN Savaraj, R Xu, H Landy, et al.Biochemical Pharmacology|September 29, 2000
Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cellsJ Zou, H Landy, L Feun, et al.European Journal of Cancer & Clinical Oncology|May 1, 1983
Clinical pharmacology of 2,5'-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ)K Lu, N Savaraj, B S Yap, et al.Cell & Developmental Biology|August 19, 2017
Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung CancerM Wangpaichitr, H Kandemir, Y Y Li, et al.Pageof 11